Jiangning Gu
-
- Cancer Genomics and Diagnostics 6
-
- Pancreatic and Hepatic Oncology Research 16
-
- Epigenetics and DNA Methylation 3
- FOXO transcription factor regulation 3
-
- Liver Disease Diagnosis and Treatment 5
- Neuroendocrine Tumor Research Advances 3
-
- Renal cell carcinoma treatment 3
- Gallbladder and Bile Duct Disorders 3
- Co-authors
- Chenghong PengHao ChenMinmin ShiBaiyong ShenHaifeng LuoJiaqiang ZhangChangyuan WangQiang Meng
- Cited by
- Cancer ResearchOncologyHepatology
In The Last Decade
Jiangning Gu
27 papers receiving 509 citations
Peers
Comparison fields: 5 of 79
- Cancer Research 158
- Oncology 158
- Hepatology 34
- Pharmacology 37
- Molecular Biology 269
Countries citing papers authored by Jiangning Gu
This map shows the geographic impact of Jiangning Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangning Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangning Gu more than expected).
Fields of papers citing papers by Jiangning Gu
This network shows the impact of papers produced by Jiangning Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangning Gu. The network helps show where Jiangning Gu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jiangning Gu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 13 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 9 | |
| 7 | 2023 | 4 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 11 | |
| 10 | 2022 | 5 | |
| 11 | 2021 | 30 | |
| 12 | 2020 | 2 | |
| 13 | 2020 | 8 | |
| 14 | 2020 | 1 | |
| 15 | 2019 | 12 | |
| 16 | 2019 | 12 | |
| 17 | 2019 | 4 | |
| 18 | 2017 | 17 | |
| 19 | 2017 | 80 | |
| 20 | 2016 | 48 |
About Jiangning Gu
Jiangning Gu is a scholar working on Cancer Research, Oncology and Biochemistry, having authored 29 papers that have together received 515 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (16 papers), Cancer Genomics and Diagnostics (6 papers), Liver Disease Diagnosis and Treatment (5 papers), Renal cell carcinoma treatment (3 papers), Neuroendocrine Tumor Research Advances (3 papers), Epigenetics and DNA Methylation (3 papers), FOXO transcription factor regulation (3 papers) and Gallbladder and Bile Duct Disorders (3 papers). The work is most often cited by research in Cancer Research (158 citations), Oncology (158 citations) and Hepatology (34 citations). Jiangning Gu has collaborated with scholars based in China, Germany and Australia. Frequent co-authors include Chenghong Peng, Hao Chen, Minmin Shi, Baiyong Shen, Haifeng Luo, Jiaqiang Zhang, Changyuan Wang, Qiang Meng, Jingjing Wu and Yi Zhu. Their work appears in journals such as Free Radical Biology and Medicine, Cancer Letters and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.